Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytesFind trials that include: Any drugs shown Results 1-3 of 3 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies Status: ActivePhase: Phase II, Phase IType: TreatmentAge: Not specifiedTrial IDs: 95-024, NCI-2017-00824, MSKCC-95024, NCI-V95-0685, P30CA008748, NCT00002663 2. Carboplatin, Docetaxel and Laboratory-Treated T Cells in Treating Patients With Refractory or Relapsed EBV-Positive Nasopharyngeal Cancer Status: ActivePhase: Phase IIType: TreatmentAge: 10 and overTrial IDs: H-25145, NCI-2013-01143, CADEN, NCT00953420 3. Immune Therapy in Treating Patients with Epstein-Barr Virus Lymphoproliferative Disorders or Epstein-Barr Virus-Associated Malignancies Status: ActivePhase: Phase IIType: Diagnostic, TreatmentAge: any ageTrial IDs: 11-130, NCI-2012-00594, NCT01498484 Select All on Page Start Over
